Daiichi Life Group Completes Share Issuance for Equity Compensation Plans

TOKYO, Jul 13 (Pulse News Wire) – Daiichi Life Group,inc. (8750.T) completed the subscription process for new share issuances related to equity compensation plans.

The issuance was approved during the board meeting held on June 22, 2026. For restricted stock awards, the company issued ordinary shares totaling ¥489.6 million, with each share priced at ¥1,814. A total of 269,800 shares were allocated among four directors and 21 executive officers of Daiichi Life Group, five directors and 22 executive officers of First Life Insurance Co., Ltd., four directors of First Frontier Life Insurance Co., Ltd., one director of First Neo Life Insurance Co., Ltd., one director of First Aipet Damage Insurance Co., Ltd., three directors of Benefit One Corp., one director of First Ryuushonzu Kabushiki Kaisha, one director of QOLead Corp., and one director of First Life Techno Cross Kabushiki Kaisha.

In addition, performance-based share awards involved the issuance of ordinary shares worth ¥858.3 million, with each share priced at ¥1,814. These shares were distributed among three directors and 14 executive officers of Daiichi Life Group, three directors and 14 executive officers of First Life Insurance Co., Ltd., three directors of First Frontier Life Insurance Co., Ltd., one director of First Aipet Damage Insurance Co., Ltd., one director of Benefit One Corp., and one director of QOLead Corp. Notably, the allocation includes individuals who held their respective positions at the end of the evaluation period from April 1, 2023, to March 31, 2026.

This issuance marks a significant step in aligning employee interests with shareholder value through comprehensive equity incentive programs.